Shanghai OPM Biosciences Co., Ltd. (SHA:688293)
China
· Delayed Price · Currency is CNY 40.66
-1.65 (-3.90%)
Last updated: Jun 6, 2025
Shanghai OPM Biosciences Revenue
Shanghai OPM Biosciences had revenue of 83.68M CNY in the quarter ending March 31, 2025, with 4.98% growth. This brings the company's revenue in the last twelve months to 301.21M, up 18.16% year-over-year. In the year 2024, Shanghai OPM Biosciences had annual revenue of 297.24M with 22.26% growth.
Revenue (ttm)
301.21M
Revenue Growth
+18.16%
P/S Ratio
15.53
Revenue / Employee
918.34K
Employees
328
Market Cap
4.68B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |